Commentary: A defence of the Health Insurance Plan (HIP) study and the Canadian National Breast Screening Study (CNBSS)

International Journal of Epidemiology

Volumn 33, Issue 1, 2004, Pages 64-65

  Miller, Anthony B ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; BREAST EXAMINATION; CANADA; CANCER INCIDENCE; CANCER MORTALITY; CANCER RESEARCH; CANCER SCREENING; HEALTH INSURANCE; HUMAN; MAMMOGRAPHY; NOTE; PATIENT REFERRAL; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SURVIVAL TIME;

BREAST NEOPLASMS; FEMALE; HUMANS; MAMMOGRAPHY; MASS SCREENING; RESEARCH DESIGN;

EID: 15044360216     PISSN: 03005771     EISSN: None     Source Type: Journal    
DOI: 10.1093/ije/dyh015     Document Type: Note

References (13)

1. Freedman DA, Petitti DB, Robins, JM. On the efficacy of screening for breast cancer. Int J Epidemiol 2004;33:43-55.
2. Gotzsche PC, Olsen O. Is screening for breast cancer with mammography justifiable? Lancet 2000;355:129-34.
3. Olsen O, Gotzsche PC. Screening for breast cancer with mammography (Cochrane Review). In: The Cochrane Library, Issue 4, 2001. Oxford: Update software.
4. International Agency for Research on Cancer Working Group. Breast Cancer Screening. Vol. 7. IARC Handbooks of Cancer Prevention. Lyon: IARC, 2002.
5. Miller AB. Screening for breast cancer with mammography. Lancet 2001;358:2164.
6. Nixon RM, Prevost TC, Duffy SW, Tabar L, Vitak B, Chen HH. Some random-effects models for the analysis of matched-cluster randomised trials: application to the Swedish Two-County trial of breast cancer screening. J Epidemiol Biostat 2000;5:349-58.
7. Nyström L, Andersson I, Bjurstam N, Frisell J, Nordenskjold B, Rutqvist L-E. Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet 2002;359:909-19.
8. Holmberg LH, Tabar L, Adami HO, Bergstrom R. Survival in breast cancer diagnosed between mammographic screening examinations. Lancet 1986;ii:27-30.
9. Tabar L, Chen H-HT, Duffy SW, Kruesmo UB. Primary and adjuvant therapy, prognostic factors and survival in 1053 breast cancers diagnosed in a trial of mammography screening. Jpn J Clin Oncol 1999;29:608-16.
10. Miller AB, To T, Baines CJ, Wall C. The Canadian National Breast Screening Study - 1. A randomized screening trial of mammography in women age 40-49: Breast cancer mortality after 11-16 years of follow-up. Ann Int Med 2002;137:305-12.
11. Miller AB, To T, Baines CJ, Wall C. Canadian National Breast Screening Study-2: 13-year results of a randomized trial in women age 50-59 years. J Natl Cancer Inst 2000;92:1490-99.
12. Blanks RG, Moss SM, McGahan CE, Quinn MJ, Babb PJ. Effect of NHS breast screening programme on mortality from breast cancer in England and Wales, 1990-8: comparison of observed with predicted mortality. BMJ 2000;321:665-69.
13. Miller AB. Effect of screening programme on mortality from Breast cancer. Benefit of 30% may be substantial overestimate. BMJ 2000;321:1527.